Pacira Pharmaceuticals (PCRX) PT Lowered to $52 at Jefferies
Tweet
Share
E-mail
Get Alerts PCRX Hot Sheet
Price: $25.90 --0%
Rating Summary:
12 Buy, 15 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 4 | New: 7
Rating Summary:
12 Buy, 15 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 4 | New: 7
Join SI Premium – FREE
Jefferies lowered its price target on Pacira Pharmaceuticals (NASDAQ: PCRX) to $52.00 (from $57.00) while maintaining a Buy rating following results.
Analyst David Steinberg trimmed FY17 Exparel revs by $8M to $283M to align with the midpoint of updated guidance.They also trim FY18-20 sales ests by 4-6%
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- XPLR Infrastructure (XIFR) PT Lowered to $16 at Jefferies
- JPMorgan Starts KADOKAWA (9468:JP) (KDKWF) at Neutral
- UP Fintech Holding Ltd. (TIGR) PT Lowered to $7.70 at Jefferies
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS Change, Analyst EPS View, Analyst PT ChangeRelated Entities
Jefferies & CoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
